Intraocular Melanoma - 24 Studies Found
| Not yet recruiting |
: Vorinostat in Patients With Class 2 High Risk Uveal Melanoma : Uveal Melanoma : 2016-12-21 : Drug: Vorinostat Study participants who meet the criteria of Class 2 uveal melanoma and no radiologic ev |
| Completed |
: Assessing the Clinical Effectiveness of Serum Biomarkers in the Diagnosis of Metastatic Uveal Melanoma : Uveal Melanoma : 2011-09-15 |
| Completed |
: Dendritic Cells Plus Autologous Tumor RNA in Uveal Melanoma : Uveal Melanoma : 2013-09-17 : Biological: Autologous Dendritic Cells loaded with autologous Tumor RNA |
| Completed |
: Study of Tumor Samples in Patients Undergoing Radiation Therapy or Surgery For Primary Melanoma of the Eye : Intraocular Melanoma : 2009-08-05 :
|
| Completed |
: Temozolomide and Bevacizumab in Treating Patients With Metastatic Melanoma of the Eye : Intraocular Melanoma : 2010-10-07 :
|
| Completed |
: Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Metastatic Melanoma of the Eye That Cannot Be Removed By Surgery : Intraocular Melanoma : 2008-08-19 : Drug: nab-paclitaxel 150 mg/m2 weekly for 3 of 4 weeks every 28 days. |
| Active, not recruiting |
: Safety and Efficacy of AEB071 in Metastatic Uveal Melanoma Patients : Uveal Melanoma : 2011-09-06 : Drug: AEB071 |
| Completed |
: Intermittent Selumetinib for Uveal Melanoma : Uveal Melanoma : 2016-05-10 : Drug: Selumetinib 100mg, 125mg, 150mg, 175mg, 200mg or 225 |
| Active, not recruiting |
: Comparison Between Fotemustin to Intensive Surveillance in Patients With High Risk Uveal Melanoma : Uveal Melanoma : 2016-07-21 :
|
| Completed |
: Transarterial Radioembolisation in Comparison to Transarterial Chemoembolisation in Uveal Melanoma Liver Metastasis : Uveal Melanoma : 2016-09-09 :
|